Physician profile
David S Stone
NPI 1871669838
$6,161.76
in general payments reported to CMS, 2019-2025
46 companies · $1,092 in 2025
The $1,092 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,160 · 2022: $1,303 · 2023: $1,409 · 2024: $1,199 · 2025: $1,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,699.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $818.79 | 2021-2025 | |
| Novo Nordisk INC | $550.83 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $500.61 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $363.81 | 2021-2024 | Rexulti |
| Glaxosmithkline, LLC. | $338.32 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $318.48 | 2024-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $308.64 | 2021-2025 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.72 | 2021-2025 | Jardiance, Ofev |
| Abbott Laboratories | $245.74 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $242.22 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $179.69 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $155.61 | 2021 | |
| Merck Sharp & Dohme LLC | $142.72 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Radius Health, INC. | $112.44 | 2021-2025 | |
| Amgen INC. | $111.87 | 2023-2025 | Evenity, Prolia, Repatha |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $102.86 | 2023-2024 | Cologuard Collection Kit |
| Philips North America LLC | $90.55 | 2021-2025 | Vest Therapy Und, (8874) Incourage |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.64 | 2021-2025 | Xifaxan |
| Esperion Therapeutics, INC. | $83.73 | 2021-2023 | Nexletol |
| Novartis Pharmaceuticals Corporation | $82.62 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $79.77 | 2022-2025 | Zoryve, Livalo |
| Bayer Healthcare Pharmaceuticals INC. | $70.60 | 2022-2025 | |
| Antares Pharma, INC. | $67.03 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Eisai INC. | $66.78 | 2021 | |
| Idorsia Pharmaceuticals US INC | $66.73 | 2022-2023 | Quviviq |
| Mylan Specialty L.P. | $63.69 | 2021-2023 | Yupelri |
| Scilex Pharmaceuticals INC. | $61.83 | 2023 | Ztlido, Elyxyb |
| Dexcom, INC. | $53.37 | 2021-2025 | Dexcom G6 Transmitter |
| Abiomed | $52.83 | 2025 | |
| Halozyme INC | $47.38 | 2023 | |
| Astellas Pharma US INC | $46.99 | 2024-2025 | Veozah |
| Sanofi-Aventis U.S. LLC | $44.04 | 2025 | |
| Phathom Pharmaceuticals, INC. | $30.74 | 2024-2025 | Voquezna |
| Baxter Healthcare | $30.56 | 2023 | Hillrom - Life 2000 Ventilation System |
| Takeda Pharmaceuticals U.S.A., INC. | $29.92 | 2024-2025 | Trintellix |
| Hologic Sales and Service, LLC | $25.86 | 2024 | Affirm Prone Biopsy System |
| Aimmune Therapeutics, INC. | $23.61 | 2024 | |
| Sanofi Pasteur INC. | $22.94 | 2025 | |
| Almatica Pharma LLC | $22.82 | 2021 | |
| Boston Scientific Corporation | $22.56 | 2025 | Watchman Flx |
| Sumitomo Pharma America, INC. | $21.22 | 2025 | Gemtesa |
| Teva Pharmaceuticals USA, INC. | $18.69 | 2022 | |
| Covis Pharma Gmbh | $17.72 | 2023 | |
| Verity Pharmaceuticals INC. | $14.54 | 2025 | Tlando |
| Alfasigma USA, INC. | $13.14 | 2021 | |
| Dynavax Technologies Corporation | $5.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.